A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study
European Journal of Cancer · 2026-11 · 248 · 117445
DOI: 10.1016/j.ejca.2026.117445 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Hui-Jen Tsai und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Oncology, National Cheng Kung University Ho…. Hauptthemen laut MEDLINE: Catechin, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Nasopharyngeal Carcinoma. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, T…
- Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei City, Taiwan; Department of Radiation Oncology, Taitung Christian Hospital, Taitung City, Taitung County, Taiwan.
- Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung City, Taiwan.
- Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
- Department of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Förderung
- National Science and Technology Council
Zitieren
APA
Tsai, H. J., Cheng, S. H., Yang, S. N., Tsou, H. H., Hsiao, C. F., Chang, Y. F., Liu, W. S., Tsai, J. T., Hsieh, C. Y., Tsai, Y. C., Tsai, M. H., Ko, J. Y., Hua, C. H., Ting, L. L., Lien, M. Y., Wu, Y. H., Tsai, S. T., Chen, J. Y., Lin, J. C., & Liu, T. W. (2026). A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study. European Journal of Cancer, 248, 117445. https://doi.org/10.1016/j.ejca.2026.117445
Vancouver
Tsai HJ, Cheng SH, Yang SN, Tsou HH, Hsiao CF, Chang YF, et al. A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study. European Journal of Cancer. 2026;248:117445. doi:10.1016/j.ejca.2026.117445
BibTeX
@article{Tsai2026,
author = {Tsai, Hui-Jen and Cheng, Skye Hung-Chun and Yang, Shih-Neng and Tsou, Hsiao-Hui and Hsiao, Chin-Fu and Chang, Yi-Fang and Liu, Wen-Shan and Tsai, Jo-Ting and Hsieh, Ching-Yun and Tsai, Yu-Chen and Tsai, Ming-Hsui and Ko, Jeng-Yuh and Hua, Chun-Hung and Ting, Lai-Lei and Lien, Ming-Yu and Wu, Yuan-Hua and Tsai, Sen-Tien and Chen, Jen-Yang and Lin, Jin-Ching and Liu, Tsang-Wu},
title = {A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117445},
doi = {10.1016/j.ejca.2026.117445}
}
EUVIMED